Imagion Biosystems Limited (IBXXF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 6.03 Million AUD | 31.14% |
| 2022 | 4.6 Million AUD | 9905.58% |
| 2021 | 46.01 Thousand AUD | -93.04% |
| 2020 | 660.97 Thousand AUD | -24.61% |
| 2019 | 876.77 Thousand AUD | 1508.3% |
| 2018 | 54.51 Thousand AUD | -31.87% |
| 2017 | 80.01 Thousand AUD | -99.43% |
| 2016 | 13.92 Million AUD | 46.7% |
| 2015 | 9.49 Million AUD | 126.63% |
| 2014 | 4.18 Million AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 FY | 6.03 Million AUD | 31.14% |
| 2023 Q3 | 4.94 Million AUD | 8.18% |
| 2023 Q4 | 6.03 Million AUD | 22.17% |
| 2023 Q1 | 4.56 Million AUD | -0.77% |
| 2023 Q2 | 4.56 Million AUD | 0.0% |
| 2022 Q2 | 3.99 Million AUD | 0.0% |
| 2022 Q4 | 4.6 Million AUD | 29.22% |
| 2022 FY | 4.6 Million AUD | 9905.58% |
| 2022 Q1 | 3.99 Million AUD | 8572.52% |
| 2022 Q3 | 3.56 Million AUD | -10.71% |
| 2021 Q1 | 37.91 Thousand AUD | -94.26% |
| 2021 FY | 46.01 Thousand AUD | -93.04% |
| 2021 Q4 | 46.01 Thousand AUD | 49.04% |
| 2021 Q3 | 30.87 Thousand AUD | -18.57% |
| 2021 Q2 | 37.91 Thousand AUD | 0.0% |
| 2020 FY | 660.97 Thousand AUD | -24.61% |
| 2020 Q1 | 451.48 Thousand AUD | -48.51% |
| 2020 Q2 | 451.48 Thousand AUD | 0.0% |
| 2020 Q4 | 660.97 Thousand AUD | 118.33% |
| 2020 Q3 | 302.74 Thousand AUD | -32.94% |
| 2019 Q1 | 18.55 Thousand AUD | -65.97% |
| 2019 Q3 | 615.01 Thousand AUD | 3215.11% |
| 2019 Q4 | 876.77 Thousand AUD | 42.56% |
| 2019 FY | 876.77 Thousand AUD | 1508.3% |
| 2019 Q2 | 18.55 Thousand AUD | 0.0% |
| 2018 Q4 | 54.51 Thousand AUD | 195.74% |
| 2018 Q2 | 52.05 Thousand AUD | 0.0% |
| 2018 Q1 | 52.05 Thousand AUD | -34.94% |
| 2018 FY | 54.51 Thousand AUD | -31.87% |
| 2018 Q3 | 18.43 Thousand AUD | -64.59% |
| 2017 Q2 | 66.63 Thousand AUD | 0.0% |
| 2017 Q1 | 66.63 Thousand AUD | 0.0% |
| 2017 FY | 80.01 Thousand AUD | -99.43% |
| 2017 Q4 | 80.01 Thousand AUD | 62.2% |
| 2017 Q3 | 49.32 Thousand AUD | -25.97% |
| 2016 FY | 13.92 Million AUD | 46.7% |
| 2015 FY | 9.49 Million AUD | 126.63% |
| 2014 FY | 4.18 Million AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -169.569% |
| Arrayit Corporation | 1.07 Million USD | -460.057% |
| Atlantic International Corp. | 2.93 Million USD | -106.053% |
| Biocept, Inc. | 12.1 Million USD | 50.133% |
| Bioqual, Inc. | 3.58 Million USD | -68.34% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -8215.677% |
| DermTech, Inc. | 54.39 Million USD | 88.899% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 98.72% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -24.915% |
| iMD Companies, Inc. | 1.12 Million USD | -439.066% |
| IDenta Corp. | 789.14 Thousand USD | -665.175% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 46.048% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -13672.029% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 24.942% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -57.829% |
| NovelStem International Corp. | 3.57 Million USD | -68.924% |
| Optigenex Inc. | 8.94 Million USD | 32.463% |
| PharmChem, Inc. | 77.35 Thousand USD | -7706.221% |
| Proteome Sciences plc | 17.15 Million USD | 64.799% |
| Response Genetics, Inc | 6.37 Million USD | 5.251% |
| Rennova Health, Inc. | 15.32 Million USD | 60.609% |
| RushNet, Inc. | 4.82 Million USD | -25.196% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -2816.596% |
| Stella Diagnostics Inc. | 6.2 Million USD | 2.618% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -235.448% |
| Todos Medical Ltd. | 38.34 Million USD | 84.254% |